Search
Anesthesiologists and biomedical engineers at Memorial Sloan Kettering Cancer Center (MSK) have modified the protective boxes commonly employed during airway procedures in infectious patients, such as intubation, creating a two-piece setup instead of the usual single unit.
Read about a few of the MSK studies being presented at the 2019 American Society of Clinical Oncology's annual meeting.
New researched published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced hepatocellular carcinoma the most common form of liver cancer.
A new study from researchers at Memorial Sloan Kettering Cancer Center has found that the majority of surgeons treating prostate cancer in the United States have extremely low annual caseloads, potentially leading to increased rates of both surgical complications and cancer recurrence.
Learn how a bladder cancer specialist diagnosed with a very rare form of the disease turned to MSK for its expertise.
Learn why it's important to get a flu shot this year.
Memorial Sloan Kettering Cancer Center (MSK) experts shared the results of their cutting-edge research at the European Society of Medical Oncology (ESMO) Congress 2023, held in Madrid, Spain, October 20 to 24, 2023. Highlights included promising advances for difficult-to-treat gastric, breast, and head and neck cancer, and a recent molecular genetics discovery.
Dose-dense chemotherapy calls for less time between doses compared with a standard treatment plan.
How cryo-electron microscopy is providing scientists at MSK with an unprecedented view of the wild and wiggly microcosm inside our cells.
A protein in blood vessels that plays a role in cancer metastasis is a promising target for delivering cancer drugs to tumors using nanoparticles.